New Director of Lady Davis Institute aiming to boost LDI’s global prominence and impact
As the new Director of the Lady Davis Institute, Dr. Stephen Robbins hopes to see the LDI gain even more global prominence.
Major construction to install new cancer-fighting linear accelerator in Radiation Oncology
Construction is under way to install a fourth linear accelerator in Radiation Oncology, making cancer treatment faster and more accurate.
Telehealth plays key role in Radiation Oncology, even though treatment is provided in person
Although radiation therapy for cancer must be administered in person, the Division of Radiation Oncology is making extensive use of telehealth to provide support to patients and keep staff in the loop.
Telehealth becomes vital nursing tool in monitoring patients’ health at home
JGH nurses in many fields are playing a key role in using telehealth to maintain contact with patients and provide the support they need at home.
Major donation for research consortium to improve outcomes of lung cancer patients
A major donation has led to creation of a JGH-based consortium to improve the outcomes of lung cancer patients through customized treatments.
JGH nursing initiative wins award for helping cancer patients manage their symptoms
A JGH nursing initiative to help cancer outpatients manage their symptoms more effectively has won an award from the Order of Nurses of Quebec.
Dr. Stephen Robbins appointed Director of Lady Davis Institute
Dr. Stephen Robbins has been appointed Director of the Lady Davis Institute, effective January 2021.
How the Segal Cancer Centre is responding to the coronavirus pandemic
The Segal Cancer Centre at the JGH has responded to COVID-19 with compassion and innovation by enabling patients can consult with oncologists by video as an alternative to face-to-face meetings.
Finding ways to speak with children about a parent’s cancer
If a parent has cancer, are children better protected if they’re shielded from the truth? No, say the books in a three-volume series that Hope & Cope has published to explain how to broach the subject with a combination of frankness and compassion.
Cellular origins of pediatric brain tumours identified
Several types of fatal pediatric brain tumours originate during early brain development, Dr. Claudia Kleinman, of the Lady Davis Institute, and her collaborators have discovered. The genetic event that triggers the disease probably occurs in prenatal cellular development.